Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.

For patients with clinically defined heart failure following AMI, ramipril results in a sustained survival benefit, and is associated with an extension of life of up to 14.5 months for, on average, 13 months treatment duration.